Changes in dementia diagnoses in Sweden during the COVID-19 pandemic.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
26 04 2022
Historique:
received: 03 01 2022
accepted: 13 04 2022
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

The COVID-19 pandemic has caused large disruptions to healthcare systems. Refocus on COVID-19 related care might have contributed to indirect effects on other healthcare areas. Care focused on acute conditions have been negatively affected although research into the effects on chronic and care intensive patient groups such as patients with dementia diseases is lacking. In this study we evaluated dementia diagnosis trends in Sweden during 2015-2020 according to International Classification of Disease version 10 coding of common dementia diseases. Regional and national statistics in the form of International Classification of Disease version 10 coding, COVID-19 incidence, mortality data, and population census data were collected from the National Institute of Health and Welfare. Logistic regression analysis was performed to identify trends of dementia diagnosis during 2015-2020. Correlation test was performed between COVID-19 incidence, mortality rates, and dementia coding. Dementia diagnosis incidence has been declining since 2015 and further decline was noted in many regions in Sweden during 2020. As COVID-19 incidence increased, fewer cases of dementia were diagnosed, a decrease that differentially impacted women and those who were advanced in age. Dementia diagnosis incidence in Sweden has been on a decline since 2015. The COVID-19 pandemic caused a further larger decline in dementia diagnosis incidence during 2020. COVID-19 incidence, but not mortality, was associated with decrease in dementia diagnosis incidence. There might be a large number of undiagnosed patients with dementia and healthcare reforms should be enacted to address this. Women and elderly are particularly vulnerable groups.

Identifiants

pubmed: 35473668
doi: 10.1186/s12877-022-03070-y
pii: 10.1186/s12877-022-03070-y
pmc: PMC9039601
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

365

Informations de copyright

© 2022. The Author(s).

Références

J Am Geriatr Soc. 2021 Dec;69(12):3389-3396
pubmed: 34664262
Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):306-14
pubmed: 19568149
J Neurol Neurosurg Psychiatry. 2005 Dec;76 Suppl 5:v2-7
pubmed: 16291918
Prog Pediatr Cardiol. 2020 Dec;59:101254
pubmed: 32837144
BMJ Open. 2021 Jun 18;11(6):e048926
pubmed: 34145019
Lancet Public Health. 2020 Oct;5(10):e543-e550
pubmed: 32979305
Front Psychiatry. 2021 Jul 28;12:711658
pubmed: 34393864
Dementia (London). 2020 Nov;19(8):2637-2657
pubmed: 30909718
Horm Metab Res. 2021 Mar;53(3):191-196
pubmed: 33530117
Open Heart. 2020 Aug;7(2):
pubmed: 32855212
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016
Infect Genet Evol. 2021 Jan;87:104647
pubmed: 33264669
J Neurol. 2021 Feb;268(2):403-408
pubmed: 32691235
Alzheimers Dement. 2020 May;16(5):770-778
pubmed: 32270625
Front Neurol. 2020 Nov 24;11:589901
pubmed: 33329337
Alzheimers Dement. 2017 Jan;13(1):1-7
pubmed: 27583652
Risk Manag Healthc Policy. 2021 Feb 15;14:575-584
pubmed: 33623448
J Med Internet Res. 2020 Sep 9;22(9):e20786
pubmed: 32810841
Prim Care Diabetes. 2021 Dec;15(6):918-922
pubmed: 34393092
N Engl J Med. 2020 Oct 8;383(15):1483-1488
pubmed: 32706956
J Med Internet Res. 2020 Oct 6;22(10):e22146
pubmed: 32903195
J Alzheimers Dis. 2018;64(4):1077-1083
pubmed: 30010124
Clin Epidemiol. 2018 Nov 16;10:1679-1693
pubmed: 30532598
Scand J Public Health. 2021 Dec 21;:14034948211064656
pubmed: 34933630
Age Ageing. 2021 Feb 26;50(2):317-325
pubmed: 33205150
Am J Geriatr Psychiatry. 2020 Jul;28(7):712-721
pubmed: 32331845
J Gen Intern Med. 2018 Jul;33(7):1131-1138
pubmed: 29508259

Auteurs

Michael Axenhus (M)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden. michael.axenhus.2@ki.se.
Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden. michael.axenhus.2@ki.se.

Sophia Schedin-Weiss (S)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden.

Lars Tjernberg (L)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden.

Anders Wimo (A)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden.
The primary care of Hudiksvall-Nordanstig, the Region of Gävleborg, Gävle, Sweden.

Maria Eriksdotter (M)

Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden.
Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.

Gustaf Bucht (G)

Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden.

Bengt Winblad (B)

Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden.
Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH